Candel Therapeutics reports Q1 EPS (28c) vs (30c) last year
PremiumThe FlyCandel Therapeutics reports Q1 EPS (28c) vs (30c) last year
5M ago
Candel Therapeutics to Present Promising Cancer Trial Data
Premium
Company Announcements
Candel Therapeutics to Present Promising Cancer Trial Data
6M ago
Candel Therapeutics to present on CAN-3110, CAN-2409 at ASCO meeting
Premium
The Fly
Candel Therapeutics to present on CAN-3110, CAN-2409 at ASCO meeting
6M ago
Candel Therapeutics presents preclinical data on immunotherapy candidate
PremiumThe FlyCandel Therapeutics presents preclinical data on immunotherapy candidate
6M ago
Candel Therapeutics’ treatment of pancreatic cancer receives orphan designation
Premium
The Fly
Candel Therapeutics’ treatment of pancreatic cancer receives orphan designation
6M ago
Candel Therapeutics Inc trading resumes
Premium
The Fly
Candel Therapeutics Inc trading resumes
6M ago
Candel Therapeutics reports Q4 EPS (38c) vs (18c) last year
PremiumThe FlyCandel Therapeutics reports Q4 EPS (38c) vs (18c) last year
6M ago
Is CADL a Buy, Before Earnings?
Premium
Pre-Earnings
Is CADL a Buy, Before Earnings?
7M ago
Candel Therapeutics Unveils Immunotherapy Breakthrough at AACR
Premium
Company Announcements
Candel Therapeutics Unveils Immunotherapy Breakthrough at AACR
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100